Skip to main content
. 2011 Jun 7;5:759–765. doi: 10.2147/OPTH.S17457

Figure 1.

Figure 1

Temporal onset of common AEs in patients receiving bimatoprost ophthalmic solution 0.03% QD during the first 12 months of treatment in the six pooled long-term glaucoma studies.

Abbreviation: AE, adverse event.